These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 28143958)
1. Ratio of matrix metalloproteinase-2 to -9 is a more accurate predictive biomarker in women with suspected pre-eclampsia. Feng H; Wang L; Zhang M; Zhang Z; Guo W; Wang X Biosci Rep; 2017 Apr; 37(2):. PubMed ID: 28143958 [TBL] [Abstract][Full Text] [Related]
2. Matrix Metalloproteinases MMP-2 and MMP-9 Occupy a New Role in Severe Preeclampsia. Timokhina E; Strizhakov A; Ibragimova S; Gitel E; Ignatko I; Belousova V; Zafiridi N J Pregnancy; 2020; 2020():8369645. PubMed ID: 33381317 [TBL] [Abstract][Full Text] [Related]
3. MMP-2 levels are elevated in the plasma of women who subsequently develop preeclampsia. Myers JE; Merchant SJ; Macleod M; Mires GJ; Baker PN; Davidge ST Hypertens Pregnancy; 2005; 24(2):103-15. PubMed ID: 16036395 [TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinases-2 (MMP-2) and matrix metalloproteinases -9 (MMP-9) are differentially expressed in different regions of normal and preeclampsia placentae. Sahay AS; Jadhav AT; Sundrani DP; Wagh GN; Mehendale SS; Joshi SR J Cell Biochem; 2018 Aug; 119(8):6657-6664. PubMed ID: 29665148 [TBL] [Abstract][Full Text] [Related]
5. Expression of Matrix Metalloproteinase-2,-7,-9 in Serum during Pregnancy in Patients with Pre-Eclampsia: A Prospective Study. Bahabayi A; Yang N; Xu T; Xue Y; Ma L; Gu X; Wang Y; Jia K Int J Environ Res Public Health; 2022 Nov; 19(21):. PubMed ID: 36361378 [TBL] [Abstract][Full Text] [Related]
6. Altered Maternal Serum Matrix Metalloproteinases MMP-2, MMP-3, MMP-9, and MMP-13 in Severe Early- and Late-Onset Preeclampsia. Laskowska M Biomed Res Int; 2017; 2017():6432426. PubMed ID: 28798935 [TBL] [Abstract][Full Text] [Related]
8. Gelatinase matrix metalloproteinase (MMP)-2 and MMP-9 of the umbilical cord blood in preeclampsia. Galewska Z; Romanowicz L; Jaworski S; Bańkowski E Clin Chem Lab Med; 2008; 46(4):517-22. PubMed ID: 18298353 [TBL] [Abstract][Full Text] [Related]
9. Gene expression analysis of MMPs in women with preeclampsia using cell-free fetal RNA in maternal plasma. Etesami E; Nikukar H; Ramezanali F; Ghotbizadeh Vahdani F; Shahhoseini M; Favaedi R; Ghaheri A; Seydabadi S; Zamanian M Pregnancy Hypertens; 2019 Jul; 17():261-268. PubMed ID: 31487650 [TBL] [Abstract][Full Text] [Related]
10. Prediction of pre-eclampsia combining NGAL and other biochemical markers with Doppler in the first and/or second trimester of pregnancy. A pilot study. Karampas GA; Eleftheriades MI; Panoulis KC; Rizou MD; Haliassos AD; Metallinou DK; Mastorakos GP; Rizos DA Eur J Obstet Gynecol Reprod Biol; 2016 Oct; 205():153-7. PubMed ID: 27599094 [TBL] [Abstract][Full Text] [Related]
11. The use of angiogenic biomarkers in maternal blood to identify which SGA fetuses will require a preterm delivery and mothers who will develop pre-eclampsia. Chaiworapongsa T; Romero R; Whitten AE; Korzeniewski SJ; Chaemsaithong P; Hernandez-Andrade E; Yeo L; Hassan SS J Matern Fetal Neonatal Med; 2016; 29(8):1214-28. PubMed ID: 26303962 [TBL] [Abstract][Full Text] [Related]
12. Assessment of annexin A5 and annexin A2 levels as biomarkers for pre-eclampsia: A pilot study. Abd El-Latif M; Azzam H; Othman M; Warda O; El-Sharawy S; Ghoneim H Pregnancy Hypertens; 2017 Apr; 8():65-69. PubMed ID: 28501283 [TBL] [Abstract][Full Text] [Related]
13. Combination of NGAL and Cystatin C for Prediction of Preeclampsia at 10-14 Weeks of Gestation. Zhang HB; Fan JM; Zhu LL; Yuan XH; Shen XW Clin Lab; 2019 May; 65(5):. PubMed ID: 31115219 [TBL] [Abstract][Full Text] [Related]
14. Prediction of pre-eclampsia during early pregnancy in primiparas with soluble fms-like tyrosine kinase-1 and placental growth factor. Rohra DK; Zeb A; Qureishi RN; Azam SI; Khan NB; Zuberi HS; Sikandar R Natl Med J India; 2012; 25(2):68-73. PubMed ID: 22686711 [TBL] [Abstract][Full Text] [Related]
15. Significant elevation of plasma matrix metalloproteinase-9 level and its ratio to matrix metalloproteinase-2 in patients with pelvic inflammatory disease. Wang PH; Tsai HT; Tee YT; Lin LY; Yang SF; Hsieh YS Fertil Steril; 2009 Nov; 92(5):1679-84. PubMed ID: 18937938 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of serum matrix metalloproteinase (MMP)-9 to MMP-2 ratio as a biomarker in hepatocellular carcinoma. Yeh HC; Lin SM; Chen MF; Pan TL; Wang PW; Yeh CT Hepatogastroenterology; 2010; 57(97):98-102. PubMed ID: 20422881 [TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinases and their inhibitors in different acute stroke subtypes. Vukasovic I; Tesija-Kuna A; Topic E; Supanc V; Demarin V; Petrovcic M Clin Chem Lab Med; 2006; 44(4):428-34. PubMed ID: 16599837 [TBL] [Abstract][Full Text] [Related]
18. The usefulness of CYFRA 21-1 to diagnose and predict preeclampsia: a nested case-control study. Kuessel L; Zeisler H; Ristl R; Binder J; Pateisky P; Schmid M; Marschalek J; Perkmann T; Haslacher H; Husslein H BMC Pregnancy Childbirth; 2016 Nov; 16(1):339. PubMed ID: 27809797 [TBL] [Abstract][Full Text] [Related]
19. Predictive value of angiogenic factors, clinical risk factors and uterine artery Doppler for pre-eclampsia and fetal growth restriction in second and third trimester pregnancies in an Ecuadorian population. Kienast C; Moya W; Rodriguez O; Jijón A; Geipel A J Matern Fetal Neonatal Med; 2016; 29(4):537-43. PubMed ID: 25708492 [TBL] [Abstract][Full Text] [Related]
20. Positive correlations between circulating adiponectin and MMP2 in preeclampsia pregnant. Eleuterio NM; Palei AC; Rangel Machado JS; Tanus-Santos JE; Cavalli RC; Sandrim VC Pregnancy Hypertens; 2015 Apr; 5(2):205-8. PubMed ID: 25943646 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]